Celularity Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.60

-0.01 (-1.39%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,977.3% upside

Low Target $7.12

Average Target $12.42

High Target $14.14

Current Price $0.60

Current
$0.60

Target
$12.42

$7.12 $12.42 avg $14.14

Scenario Analysis

Bear Case

$7.12

1,090.8%

Low target

Base Case

$12.42

+1,977.3%

Avg target

Bull Case

$14.14

+2,264.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.35

-86.3% from high

52-Week Low

$0.63

+-4.8% from low

Target vs 52W High

$12.42

+185.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%